ELRIG Drug Discovery 2026
Event: ELRIG Drug Discovery 2026
Dates: October 14–15, 2026
Venue: ExCeL London
Location: London, United Kingdom
ChemPartner Booth: B15
Attending from ChemPartner:
Kieran Casey — Senior Director, Business Development
Judy Hawry — Associate Director, Business Development
Kamila Pawlicka, PhD — Manager, Scientific Communication
Ian Willox — Executive Director, Business Development
Poster Presentations:
Poster #64 — Kieran Casey
Title:
Integrated Biologics Discovery Platform: AI-Augmented Design, Experimental Validation and Developability Assessment for Complex Antibody Modalities
Poster #143 — Judy Hawry
Title:
Development and Functional Evaluation of Multispecific Antibodies with Single and Multiple Cytotoxic Payloads for Next-Generation ADCs
Poster #254 — Kamila Pawlicka, PhD
Title:
Antibody–Oligonucleotide Conjugates: From Stochastic Conjugation to Site-Specific Click Chemistry
Poster Session Dates: October 14–15, 2026
Poster Session Time: 1:30–2:00 PM / 13:30–14:00
Poster Session Location: Exhibition Area, ExCeL London
ChemPartner will be exhibiting at ELRIG Drug Discovery 2026 in London. Visit us at Booth B15 to meet our team and learn more about ChemPartner’s integrated drug discovery capabilities.
ChemPartner will also be presenting three posters covering biologics discovery, next-generation ADCs, and antibody–oligonucleotide conjugates. Join our team during the poster sessions from 13:30–14:00 on October 14 and 15 in the exhibition area.
Let’s Connect:
Whether you’re optimizing a lead series, designing a conjugate program, or planning your path to IND, our team would love to hear about your goals and discuss how ChemPartner can support your program.
Questions? Contact us
